COVID-19 Vaccine Timeline Accelerated

March 19, 2021

Good news! The State announced several key updates regarding the phasing and pace of Connecticut’s COVID-19 vaccine roll-out.

First, the next phase of the roll out, which expands eligibility to individuals aged 45 to 54, begins today, March 19. 

The State also announce that general availability to all individuals 16-years-of-age and older will begin ahead of schedule. Eligibility is tentatively scheduled to begin for this age group on Monday, April 5. This acceleration comes as the State was informed by the Biden administration that we should anticipate receiving a significant increase in supplies of all three federally authorized vaccines over the next several weeks.
 
It’s important to note that these dates are for appointment eligibility. They are not a guarantee of a timeline in which you will receive the vaccine.

Connecticut continues to rank among the top five states in the nation in the percentage of our population that has been vaccinated. Individuals who are currently eligible to receive the vaccine in Connecticut include:

  • All individuals age 55 and older;
  • Healthcare personnel;
  • Medical first responders;
  • Residents and staff of long-term care facilities;
  • Residents and staff of select congregate settings; and
  • PreK-12 school staff and professional childcare providers.

All eligible individuals in Connecticut who would like to receive the vaccine must make an appointment in advance. Information on making an appointment and finding the closest available clinic can be found online at ct.gov/covidvaccine. Those without access to the internet can call the Connecticut’s Vaccine Appointment Assist Line at 877-918-2224. The assist line is available seven days a week from 8:00 a.m. to 8:00 p.m.

While a large portion of eligible residents have received at least the first dose of the COVID-19 vaccine, there are still a number of residents that need to be vaccinated. We must have patience as we wait to roll up our sleeves to get the COVID-19 vaccine.